Saved Articles
My Lists
My Page
My Content
Log In
360° Search
Network
Hot Spots
Trends
Time Series
Advanced Search Options >>
Home
Global Issues
Technology
Science
Business
Energy
Countries
Carr Communications
Type:
Company
Name:
Carr Communications
Quotes
"I look forward to working with Benitec and Duke University on this important program," Dr. Gish commented.
"
This is the first time that this therapeutic modality is being tested in humans, and if it is successful I believe it can be a significant step forward, not only for HCV treatment but potentially also as a treatment modality for Hepatitis B
"
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT ... [Published Yahoo! Finance - Apr 16 2013]
More Content
All (1)
|
News (1)
|
Reports (0)
|
Blogs (0)
|
Audio/Video (0)
|
Fact Sheets (0)
|
Press Releases (0)
sort by:
Date
|
Relevance
Benitec Selects University of California, San D...
[Published Yahoo! Finance - Apr 16 2013]
1
In Focus
Peter French
Benitec Biopharma Ltd
,
Australian Securities Exchange
University of California San Diego
,
National institutes of Health
,
University of California at San Diego School of...
,
[more]
American College of Physicians
Duke University
University of California
Phase I/II
,
Health Science
,
Clinical trials
,
[more]
Antiviral
RNAi
Hepatitis C
modality
Therapeutics
DNA Vector
hepatocyte
treatments
Transduction
Infection
RNA Interference
Huntington's Disease
Sydney (Australia)
Australia
Biology
,
Medicine
Pharma & Biotech
Yahoo! Finance
Content Volume
Network
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy
Some image thumbnails are sourced from
Freebase
, licensed under
CC-BY
Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.